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ABSTRACT
Chlamydia trachomatis is an obligate intracellular
bacterium that exhibits a unique biphasic develop-
mental cycle that can be disrupted by growth in the
presence of IFN-c and b-lactams, giving rise to an
abnormal growth state termed persistence. Here we
have examined the expression of a family of
non-coding RNAs (ncRNAs) that are differentially
expressed during the developmental cycle and the
induction of persistence and reactivation. ncRNAs
were initially identified using an intergenic tiling
microarray and were confirmed by northern
blotting. ncRNAs were mapped, characterized and
compared with the previously described chlamydial
ncRNAs. The 50- and 30-ends of the ncRNAs were
determined using an RNA circularization procedure.
Promoter predictions indicated that all ncRNAs
were expressed from p
66 promoters and eight
ncRNAs contained non-templated 30-poly-A or
poly-AG additions. Expression of ncRNAs was
studied by northern blotting during (i) the normal
developmental cycle, (ii) IFN-c-induced persistence
and (iii) carbenicillin-induced persistence.
Differential temporal expression during the develop-
mental cycle was seen for all ncRNAs and distinct
differences in expression were seen during IFN-c
and carbenicillin-induced persistence and reactiva-
tion. A heterologous co-expression system was
used to demonstrate that one of the identified
ncRNAs regulated the expression of FtsI by
inducing degradation of ftsI mRNA.
INTRODUCTION
The pathogenic chlamydiae are obligate intracellular bac-
terial pathogens that cause important human diseases.
Chlamydia trachomatis is the leading cause of preventable
blindness in developing countries (1) and the most
commonly reported sexually transmitted bacterial infec-
tion worldwide (2). Chlamydia trachomatis has been
implicated in more serious disease sequelae that have
been proposed to arise due to chronic inﬂammatory
conditions associated with persistent infections [reviewed
in (3)]. Chlamydia alternates between two morphological
forms, the Elementary Body (EB) and the Reticulate Body
(RB) (4). EBs are extra-cellular, metabolically inert forms,
responsible for dissemination of infection by their ability
to attach to and invade susceptible cells. Upon infection,
EBs are internalized in membrane bound vacuoles termed
inclusions. EBs differentiate into metabolically active
forms, termed RBs and undergo repeated cycles of
binary ﬁssion, leading to secondary differentiation back
to EBs. The host cell then lyses or everts the inclusion
(5), releasing EBs, that then infect neighboring cells
[reviewed in (6)]. Under stressful growth conditions,
imposed by immunological responses, antibiotics or
nutrient deprivation, the developmental cycle is disrupted,
resulting in the appearance of large, aberrant RBs
[reviewed in (7)].
The normal developmental cycle and persistence in the
presence of IFN-g have been studied using DNA
microarrays (8,9) and cell-biology techniques but the
mechanisms for coordinated gene regulation and the
changes associated with IFN-g-induced persistence
remain largely unknown (10). Temporal control of gene
expression during the developmental cycle does not
correlate with sigma factor expression (11) although one
of the prototypical late genes, hctB (encoding one of the
bacterial histone-like proteins) has been shown to be
under control of the alternative sigma factor, s
28 (12).
Interestingly, the other chlamydial histone-like protein,
hctA, is expressed from a s
66 promoter (13) (s
66 is analo-
gous to the major sigma factor s
70 in Escherichia coli),
indicating that control of late gene expression may be
more complex than an expression cascade directed by
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have shown that two representative mid-cycle genes are
up-regulated under the inﬂuence of increased DNA super-
coiling but the three representative late genes studied
showed little or no response to changes in DNA supercoil-
ing. The effect may be due to the increased G+C content
of the promoter elements, speciﬁcally in the  10 and
spacer regions. Grieshaber et al. (15) have shown that
translation of hctA mRNA is controlled by the expression
of a non-coding RNA [ncRNA, also termed small RNAs
(sRNA)]. These ﬁndings were originally described in a
co-expression study in E. coli in which expression of
IhtA (Inhibitor of HctA) was able to rescue E. coli from
the lethal effects of HctA expression (16). Subsequently
these studies were extended and tested in C. trachomatis
and it was determined that expression of IhtA translation-
ally silenced the hctA mRNA but had no effect on the
transcription of the hctA gene (15).
Identiﬁcation of bacterial ncRNAs has increased
dramatically with the advances in genomic technology
and the appreciation of the importance of these
non-coding molecules in regulatory pathways [reviewed
in (17,18)]. Experimental approaches to identifying
ncRNAs [reviewed in (19,20)] have been diverse and
include (i) direct metabolic labeling of abundant
ncRNAs and detection by gel electrophoresis, (ii) genetic
screens for regulatory phenotypes that mapped to
non-coding regions, (iii) cloning of size fractionated
RNAs, (iv) bioinformatic identiﬁcation of conserved
intergenic regions, (v) co-puriﬁcation with RNA-binding
proteins, (vi) microarray analysis of intergenic regions and
(vii) deep-sequencing of bacterial transcriptomes.
Albrecht et al. (21) have recently determined the
transcriptomes of C. trachomatis L2b/UCH-1/proctititis
EBs and RBs using a deep-sequencing approach. The
sequence analyses were done on gradient-puriﬁed EBs
and RBs at 24h post infection (PI). Matched libraries
were used to compare normal samples with samples that
had been enriched for primary mRNA transcripts by
removal of RNAs containing 50-P groups (generally
considered to be processed molecules) and the removal
of 50-PPP molecules (generally considered to be primary
transcripts) by removal of the pyrophosphate group and
ligation of a 50-speciﬁc linker. They mapped 366 transcrip-
tional start sites using this procedure. This analysis
revealed fundamental differences between the transcrip-
tomes of RBs and EBs. In addition, the analyses identiﬁed
16 putative ncRNAs in intergenic regions and 25 small
anti-sense RNAs in ORFs.
We have used an Affymetrix Custom microarray that
contains the intergenic regions of C. trachomatis serovar D
to predict putative ncRNAs. Predicted ncRNAs were then
veriﬁed using northern blotting and transcript mapping
procedures. Expression of conﬁrmed ncRNAs were
shown to have developmentally regulated expression
patterns, were subject to RNA modiﬁcation and showed
changes in expression when the organism were grown in
persistence-inducing conditions in the presence of IFN-g
and carbenicillin. These regulatory RNAs may play a
signiﬁcant role in the control of transcription and transla-
tion of stage-speciﬁc genes and proteins in C. trachomatis
and may contribute signiﬁcantly to the temporal controls
required for the differentiation processes associated with
the developmental cycle.
MATERIALS AND METHODS
Chlamydia trachomatis growth and cell culture
Chlamydia trachomatis serovar D (strain UW-3/Cx) was
grown in HeLa 229 cells cultivated at 37 C with 5% CO2
in high glucose-containing DMEM (Cellgro, Mediatech)
supplemented with 10% heat-inactivated FBS. EBs were
puriﬁed on density gradients of RenoCal-76 (Bracco
Diagnostics, NJ, USA) as previously described (8).
Monolayers were pre-treated with DEAE-Dextran
(30mg/ml) and infected at a multiplicity of infection
(MOI) of 1. PI timing began immediately following the
addition of infectious EBs to the monolayers. Growth in
the presence of IFN-g was done as described previously
(10). IFN-g (5ng/ml) was used to induce persistence. The
amount of IFN-g used was determined based on a titra-
tion experiment for the minimum amount of IFN-g that
induce persistence and allowed for reactivation.
Carbenicillin-persistence was induced by adding 2mg/ml
antibiotic to the media at the time of infection. Similar
to the IFN-g experiments, the amount of carbenicillin
used was determined by a titration experiment that
allowed for reactivation.
RNA puriﬁcation
Total RNA was puriﬁed from infected HeLa 229 cultures
(9 10
5 cells per well cultivated as monolayers in six well
culture plates) at various times PI. At the designated times
PI, the culture media was discarded and cells lysed in 1ml
per well lysis buffer containing Proteinase K (0.167mg/ml)
(MasterPure
TM, Epicentre) and total nucleic acid was
isolated. An aliquot of the lysate (300ml) was treated
with RNase A (0.0167mg/ml) and used to purify DNA.
The remainder of the lysate was treated with DNase I
and used for total RNA preparation according to manu-
facturer’s instructions (MasterPure, Epicentre). Puriﬁed
DNA was quantiﬁed by qPCR and used for RNA nor-
malization to calculated C. trachomatis genome numbers
as previously described (22). RNA for microarray analysis
was further puriﬁed from residual contaminating DNA by
treating with DNase I (0.3U/1mg RNA) at 37 C for 1h
(TurboDNAFree, Ambion, TX, USA). RNA was then
precipitated using sodium acetate (0.1 volume) and
ethanol (3 volumes) overnight at  20 C. RNA was then
pelleted by centrifugation, washed with 80% ethanol and
re-suspended in DPEC water (1mg/ml). RNA (250mg) was
then enriched using the MICROBEnrich
TM (Ambion) and
MICROBExpress
TM (Ambion) protocols, resulting in the
removal of a signiﬁcant portion of HeLa cell
polyadenylated mRNA, 18S and 28S rRNAs in addition
to bacterial 16S and 23S rRNA.
RNA was reverse transcribed, hybridized, washed,
stained and scanned according to the Prokaryotic
sample and array processing section in the GeneChip
Expression Analysis Technical Manual (Affymetrix).
In short, cDNA was generated from enriched RNA
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USA) and Superscript RT II (Invitrogen). Following
cDNA generation, RNA was removed by adding NaOH
(1N) and incubating for 30min at 65 C followed by neu-
tralization in HCl (1N). cDNA was then puriﬁed using
MinElute columns (Qiagen). cDNA was then fragmented
using DNase I (Amersham) using 0.6U/1mg of cDNA
generated. Fragmented cDNA products were then
end-labeled using GeneChip DNA labeling Reagent
(Affymetrix) and Terminal Deoxynuceotidyl Transferase
(Promega). Fragmented and labeled cDNA were analysed
using 4–20% TBE gels (Invitrogen) using a gel shift assay
using NeutrAvidin (NeutrAvidin, Pierce). The hybridiza-
tion cocktail, consisting of labeled cDNA, control B2
oligo (Affymetrix), herring sperm DNA (Promega) and
BSA (Invitrogen) was then hybridized to MPAUT-1
GeneChip and incubated for   16h in the Affymetrix
Hybridization Oven 640 (Affymetrix) at 45 C rotating at
60r.p.m. Samples were then washed and stained on the
Affymetrix Fluidics Station 450 (Affymetrix) using
Streptavidin (Pierce Chemical), Anti-Streptavidin
antibody (Vector Labratories) and R-Streptavidin
Phycoerythrin (Molecular Probes) and using ﬂuidics
protocol ProKGE-WS2_450 in GCOS 1.1 (Affymetrix).
After washing and staining, completed chips were
scanned using the Genechip Scanner 3000 (Affymetrix).
Data was scaled using GCOS 1.1 (Affymetrix) to a mean
intensity of 1000 using the C. trachomatis ORFs as a
scaling mask. The pivot ﬁle for the sample was then
saved in GCOS as a text tab delimited ﬁle and the data
was imported into GeneSpring 7.2 (Agilent) for data
analysis.
RNA circularization, cDNA synthesis and cloning for
50-/30-end sequencing
The procedure for RNA 50-/30-end sequencing has been
described previously (23) and was used with some modi-
ﬁcations. A total of 8mg of DNA-free total RNA prepared
from 24h PI cultures was treated with 10 U tobacco acid
pyrophosphatase (Epicentre, WI, USA) for 30min at 37 C
to convert 50-triphosphate groups of primary transcripts
to 50-monophosphates. Following organic extraction,
RNA was treated overnight at 17 C with 40U of T4
RNA ligase (New England Biolabs, MA, USA) to
circularize transcripts. Following organic extraction and
ethanol precipitation, 1.5mg of self-ligated RNA was
converted to cDNA using gene speciﬁc reverse primes
and the Superscript III (200U) reverse transcription kit
(Invitrogen) in a 20ml reaction. Incubation was carried
out in 20min intervals at 42, 50, 55 and 60 C. After
heat inactivation of the reverse transcriptase for 5min at
85 C, cDNA was treated with 1U of RNase H (New
England Biolabs) at 37 C for 20min. A total of 1mlo f
the reaction served as template in a subsequent standard
25ml PCR reaction using 1  Advantage 2 Polymerase Mix
[TITANIUM Taq DNA Polymerase, TaqStart Antibody
(1.1mg/ml)], 1  Advantage 2 SA PCR Buffer [Tris–HCl
(pH 8.5), 1mM, KCl 5mM, MgCl2 0.2mM] and 0.2mM
dNTP (Clontech, CA, USA) and primer pairs designed to
amplify products representing successful self-ligated
ncRNA transcripts. PCR products were separated by
10% PAGE TBE gel electrophoresis (BIORAD, CA,
USA) and fragments of the expected size were excised,
incubated overnight in 10mM Tris–HCl buffer then
re-ampliﬁed using the aforementioned PCR protocol.
PCR products were separated by 3% agarose gel electro-
phoresis and fragments of the expected size were excised,
puriﬁed and cloned into the pCR2.1-TOPO vector
(Invitrogen). Positive colonies were picked, grown over-
night in LB media with carbenicillin (50mg/ml) and
plasmid were prepared using MiniPlasmid Prep
(Qiagen). Plasmids were sequenced using a standard
M13 Forward primer.
NORTHERN BLOTTING
Northern blotting was performed using 10%
TBE–PAGE–Urea gels for RNA electrophoresis in 1 
TBE buffer. RNA was transferred by electro-blotting,
using plate electrodes, for 1h at 50V, using 1  TBE
buffer as transfer medium. Zeta-probe GT nylon
membranes (BIORAD) were used for electro-blotting.
Single-stranded biotin-labeled RNA Probes were
prepared using a MAXIscript T7 Kit (Ambion). Target
sequences were ampliﬁed by PCR using chlamydial
DNA as a template and a minimal T7 promoter
sequence was added 50 of the anti-sense strand. The
resultant PCR fragment was fractionated on agarose
gels, extracted and used as a template for a larger scale
PCR reaction. The PCR product was puriﬁed and was
used as a DNA template for an in vitro transcription
reaction using the MAXIscript T7 kit and
biotin-16-UTP (Roche, IN, USA). The reaction was
carried out for 1h at 37 C, DNase treated for 15min at
37 C, then the reaction was stopped by addition of 1ml
0.5M EDTA. Buffer components and excess NTPs
were removed by gel ﬁltration using NucAway Spin
Columns (Ambion). Hybridization was carried out
in UltraHyb (Ambion) medium overnight at 68 C.
Blots were washed using NorthMax Low Stringency
Buffer (Ambion) at room temperature (2 5min)
and with NorthMax High Stringency Buffer (Ambion)
at 68 C( 2  60min). Northern blots were developed
using alkaline phosphatase and streptavidin according
to manufacturer’s protocols (BrightStar
TM BioDetect,
Ambion).
Quantitative RT–PCR
Primer/probe sets have been designed for C. trachomatis
ompA, ftsI and CTIG270 using Primer Express software
(Applied Biosystems). Standard curves were performed
for each gene using puriﬁed chromosomal template
DNA at concentrations ranging from 10 to 0.001ng/ml
(data not shown). Assays were performed (Universal
PCR System, Applied Biosystems) using DNA prepar-
ations of a portion of the sample for RNA puriﬁcations
that were used for northern blotting. Bacterial genome
copy numbers were estimated by converting triplicate
measurements of mean critical threshold (Ct) values to
DNA concentrations (using Standard curves) and
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calculated molecular mass of the bacterial genome (7000
Sequence Detector, ABI Prism).
Functional analysis of CTIG270 in an E. coli surrogate
system
The ftsI gene was fused in frame to a 50-FLAG-tag
sequence (N-DYKDDDDK-C) and cloned under the
control of a plac promoter (from pCR2.1, Invitrogen)
The FLAG-TAG was added using PCR with oligonucleo-
tides containing the motif. Cloning was carried out in a
promoterless pSMART-LCAmp (Lucigen, WI, USA).
PCR was used to add an FseI site to the 30-end and
50-end of the promoter and the FLAG-tagged ftsI, respect-
ively. Both amplicons were digested with FseI followed by
ligation. The fusion product was then ampliﬁed by PCR
and blunt end cloned into pSMART-LCAmp. CTIG270
was cloned under the control of an arabinose responsive
promoter (pBAD) in pRANGER-BTB vector (Lucigen).
Escherichia coli transformed with both plasmids was
induced with IPTG and/or arabinose. Escherichia coli
was harvested and analysed using northern blotting for
both mRNA and ncRNA.
Escherichia coli transformed with both plasmids
was grown to an OD600 of 0.6. The culture was split
into three tubes. One tube was induced with arabinose
(0.2%), the second tube was induced with IPTG (1mM)
and the third one was uninduced. All three tubes were
incubated at 37 C on a shaker for 2.5h. A sample was
collected from each test condition and cells were
centrifuged. Bacterial cells were used to prepare RNA
(MasterPure, Epicentre) for northern blotting and
protein for western blotting. Following sample collection
each culture tube received the second inducer. The ﬁrst
tube was induced with IPTG (1mM), the second tube
was induced with arabinose (0.2%) and the third tube
was induced with both IPTG (1mM) and arabinose
(0.2%). The culture tubes were incubated at 37 Co n
a shaker for 2.5h and a second sample was collected
from each tube as previously mentioned. Culture tubes
were incubated at 37 C on a shaker for 2.5h and
the third sample was collected as previously mentioned.
RNA and protein samples were resolved by gel
electrophoreses and loading was normalized using OD600
measurements. Protein samples were resolved on a
NuPAGE Bis–Tris gel and transferred onto a PVDF
membrane according to manufactures instructions
(Invitrogen). Western blotting was carried out using the
ProteoQwest
TM
FLAG Chemiluminescent western blotting
kit (SIGMA-ALDRICH, MO, USA). RNA samples used
for CTIG270 detection were resolved on a 10% Urea
PAGE gels, while RNA samples for ftsI detection were
resolved on a 1% formaldehyde agarose gel
(NorthernMax
TM, Ambion). RNA was then transferred
to a Zeta probe GT Nylon membranes according to
manufacturer’s instructions (BIORAD). Northern
blotting was carried out using biotinylated RNA probes
speciﬁc to CTIG270 and ftsI.
RESULTS AND DISCUSSION
Design, construction and testing of the chlamydial
intergenic microarray
Using intergenic microarrays to determine the expression
of ncRNAs represents a direct approach to screen for
ncRNAs. We have designed and constructed a
GeneChip Custom Affymetrix microarray to determine
the expression levels of ORFs and untranslated elements
in intergenic regions (IGRs) of trachomatis D (strain
UW-3/CX) based on the genomic sequence (24). The
intergenic regions of C. trachomatis D genome that are
50bp or more are represented on the microarray as 25nt
probes tiled head to tail and covering the intergenic
regions on both strands. The MICROBExpress
TM
protocol was chosen to enrich for bacterial mRNA and
ncRNA based on its superior signal to noise ratio
compared with other enrichment protocols (data not
shown). Equivalent quantities of RNA were used and pro-
cessed according to the Expression and Analysis Technical
Manual, Prokaryotic Probe Processing (Affymetrix).
Criteria for identiﬁcation of C. trachomatis ncRNAs
Potential ncRNAs were named using the IGR number
corresponding to the downstream ORF using the CT
numbers deﬁned by Stephens et al. (24), e.g. an ncRNA
located upstream of CT241 is referred to as CTIG241.
Chlamydia trachomatis D RNA collected from 40h PI
samples was processed and used to characterize the ex-
pression of ncRNAs. Identiﬁcation of potential ncRNAs
was based on a number of criteria including: (i) sequential
probes showing simultaneous expression (three or more),
(ii) high levels of ﬂuorescence (more than 1000), (iii) G+C
ratio of the expressed region (elevated G+C ratios were
noted in many of the original molecules that tested
positive by northern blotting), (iv) presence of
Rho-independent terminators at the presumed end of the
ncRNA (not an absolute requirement) and (v) genomic
conservation with other chlamydial species (not an
absolute requirement). An example of this type of
analysis is shown in Figure 1A in which the expression
of a potential ncRNA (CTIG241) is compared with
expression of tRNA-Leu-2. The IGRs and ﬂanking
ORFs are shown with corresponding expression levels
and G+C content. Housekeeping ncRNAs were used as
a validation tool for the microarray analyses as shown in
Figure 1B. These data are shown in Table 1. We were able
to detect all 37 tRNAs predicted in the genome of
C. trachomatis D (including the tRNA-Leu-2 gene in
Figure 1A). In addition, a number of highly conserved
ncRNAs found in other bacterial genera were also
detected. These included: (i) tmRNA, associated with the
release of stalled ribosomes and the incorporation of a
short peptide tag that targets the partial protein product
for degradation (25), (ii) 4.5S RNA which forms part of a
ribonucleoprotein complex that plays a role in protein
secretion (26) and (iii) M1 RNA, which forms the catalytic
subunit of RNase P, involved in 50-tRNA processing (27).
Chlamydia trachomatis D expressed 34 other intergenic
sequences that met the criteria for detection of ncRNA
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that could be classiﬁed as cis-acting anti-sense molecules
in that the expressed transcript overlapped the 30-end of a
transcript from an annotated gene in the opposite
direction [e.g. CTIG270 ncRNA and ftsI gene, CTIG153
ncRNA and CT152 (lolD)] and the previously described
anti-sense transcripts from the cryptic plasmid pCHL1
(21,28). Intergenic, potential ncRNA were also found
that ﬁt into the category of trans-acting molecules, eight
of which are shown in Figure 1B (CTIG241, 327, 356, 360,
498, 504, 643 and 684) and the remainder are listed in
Table 1 (16 predicted ncRNAs were conﬁrmed by
northern blot analysis, as listed in Table 1). The latter
category included the recently described trans-acting
ncRNA from C. trachomatis, IhtA (15), which has been
shown to translationally silence expression of the chla-
mydial histone HctA in a heterologous E. coli
co-expression system. Sequences representing predicted
ncRNAs reported in Table 1 were checked for putative
ORFs using GLIMMER ver. 3.02 (29). Sequences were
submitted to GLIMMER webserver (http://www.ncbi.
nlm.nih.gov/genomes/MICROBES/glimmer_3.cgi).
Sequences were also inspected by VectorNTI ver. 11 for
start codons (ATG, GTG, TTG) that are in frame with a
stop codon (TAA, TGA, TAG) that encoded ORFs >20
amino acids. Both methods showed that the only putative
ORF might be located within the plasmid anti-sense tran-
script, a putative peptide of 57 amino acids with a TTG as
its start codon and no identiﬁable Shine Delgarno
upstream of the start codon. Based on these results,
there is strong evidence that ncRNAs in Table 1 do not
represent un-annotated ORFs.
Characterization of ncRNAs in C. trachomatis D
A subset of ncRNAs (10) was chosen for further analysis
based on their expression levels at 24 and 48h PI and
expression differences during IFN-g-induced persistence.
These were compared with the previously described IhtA
Figure 1. Identiﬁcation of potential ncRNAs. (A) Criteria for identiﬁcation involved the expression levels of a contiguous intergenic regions, G+C
ratio and position with respect to ﬂanking ORFs. Shown here is a comparison of the CTIG241 potential ncRNA and the tRNA-Leu. Threshold
levels for inclusion are shown as pink bars across the tiled intergenic regions. Each of the circles in the upper panel indicate separate 25-mer probes
for the upper and lower strands and their expression levels. The ﬂanking ORFs are indicated as a single circle on one strand according to their
orientation. (B) Northern blotting of potential ncRNAs from C. trachomatis at 40h PI. Housekeeping small RNAs (RNase P, 4.5S RNA and
tRNA-Leu-2) and several novel (CTIG153, 241, 270, 327, 356, 360, 498, 504, 643 and 684) and previously described IhtA (15) and plasmid anti-sense
transcripts (28) RNAs are shown. Chlamydial ncRNAs were probed with strand-speciﬁc, biotin labeled probes using equivalent amounts of
non-enriched RNAs.
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scripts (21,28). These included cis-acting ncRNAs
(CTIG153, 270 and pCHL1.2), potential trans-acting
ncRNAs [CTIG241, 327, 356, 498, 504, 643, 675 (IhtA)
and 684] and a potential riboswitch-like ncRNA
(CTIG360)
We determined the 50- and 30-ends of each molecule
using an RNA circularization assay previously developed
to assess the poly-A status of RNAs (23,30). A schematic
representation of the procedure is shown in Figure 2A.
Brieﬂy, total RNA of a 24h PI sample was treated with
tobacco acid pyrophosphatase (to convert primary
triphosphate to monophosphate groups) and subjected
to end circularization by T4 RNA ligase. Guided by the
intergenic microarray results we designed primers for
cDNA synthesis of circularized RNA. After cDNA
synthesis, junction fragments were ampliﬁed by PCR
(Figure 3A), cloned and sequenced (10 clones per
reaction). This analysis revealed the transcription start
sites (TSS in Figure 2B) for all 12 ncRNAs, including
those with more than one species (CTIG643.1/2 and
pCHL1.1/2, each pair having the same 50-end). The
smaller fragment of CTIG153 could not be determined
due to the constraints on primer design presented by the
small size of the transcript. The 30-end of each of the
transcripts was also determined. The 30-ends marked
with an asterisk in Figure 3B were determined to have
non-templated additions that were of variable sizes.
Generally, speciﬁc transcripts had between 3–5 added
nucleotides but the largest found was 27nt. Although
the additions were predominantly poly-A, several
non-templated additions contained G residues.
Table 1. Results of the late cycle intergenic microarray experiment showing all known ncRNAs [tRNA, tmRNA, 4.5SRNA, 5SRNA, M1RNA,
ihtA(15) and pCHL1 plasmid anti-sense transcripts(21,28)] in addition to potential ncRNAs (NA, not attempted)
Name Approximate size Class
a A.F.U. Northern Deep sequencing (21)
Seq Northern
37 tRNAs 75–100 tRNA 25927 NA ˇ NA
tmRNA 525 PI 24598 NA ˇ Positive
4.5S RNA 100 PI 15917 Positive ˇ Positive
5S rRNA 125 Ribosomal 32001 NA ˇ NA
M1 RNA 400 PI 20235 Positive ˇ NA
ihtA 150 trans/30-UTR 9938 Positive ˇ Positive
pCHL1 500/220 Cis NA Positive ˇ Positive
CTIG153 150/100 Cis 884 Positive ˇ Positive
CTIG241 75 Trans 6073 Positive ˇ Positive
CTIG270 100 Cis 994 Positive ˇ NA
CTIG327 250 Trans 1926 Positive   NA
CTIG356 225 trans/UTR 7238 Positive ˇ Positive
CTIG360 200 trans/Riboswitch 4533 Positive   NA
CTIG498 100 trans/30-UTR 3976 Positive   NA
CTIG504 75 trans/30-UTR 3959 Positive   NA
CTIG582 200 Trans 2135 Positive   NA
CTIG643 650 Trans 7279 Positive ˇ NA
CTIG684 100 Trans 1420 Positive ˇ Negative
CTIG805 200 Trans 5677 Positive ˇ Negative
CTIG809 125 Trans 748 Positive   NA
CTIG857 225 Trans 772 Positive   NA
CTIG001 125 Trans 1396 Negative   NA
CTIG059 50 Trans 1281 Negative   NA
CTIG072 175 Trans 2780 Negative   NA
CTIG181 75 Trans 4001 Negative   NA
CTIG195 200 Trans 1852 Negative   NA
CTIG237 325 Trans 6378 Negative   NA
CTIG256 150 Trans 1941 Negative   NA
CTIG268 175 trans/50-UTR 5765 Negative   NA
CTIG323 225 Trans 4479 Negative ˇ NA
CTIG433 75 Trans/50-UTR 2723 Negative   NA
CTIG442 200 Trans/30UTR 2339 Negative   NA
CTIG444 125 Cis 3620 Negative   NA
CTIG449 125 Trans 4248 Negative ˇ NA
CTIG592 150 Trans 1335 Negative   NA
CTIG660 125 trans/30-UTR 14347 Negative   NA
CTIG663 250 Trans 2784 Negative   NA
CTIG775 175 Trans 2877 Negative   NA
CTIG813 225 Trans 1364 Negative   NA
CTIG864 125 Trans 19393 Negative   NA
Approximate sizes are based on the array (except for plasmid anti-sense transcript), the potential functional class, the average ﬂuorescence of the
probes representing the ncRNA.
aClass of ncRNA refers to its presumed mode of action. PI is protein interaction.
A.F.U., average ﬂuorescence units.
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enzymes that can add nucleotides to the 30-ends of
RNA, namely Poly(A) polymerase I (PAP I) (31) and
Polynucleotide phosphorylase (PNPase) (32) and that
both enzymes were involved in modulating RNA stability
(33,34). PAP I, an enzyme belonging to the nucleotidyl-
transferase family, adds poly(A) extensions to the 30-ends
of mRNAs, as well as to tRNA and rRNA (35). PNPase
not only synthesizes long, heteropolymeric tails in vivo,
but also accounts for all of the observed residual
polyadenylylation in PAP I deﬁcient strains (36).
Polyadenylation of RNAs by PAP I in E. coli plays a
signiﬁcant role in mRNA decay and general RNA
quality control. It has been demonstrated that >90% of
E. coli ORFs transcribed during exponential growth
undergo some degree of polyadenylation by PAP I,
either as full-length transcripts or decay intermediates
(37). In prokaryotes, polyadenylated RNA molecules are
usually degraded more efﬁciently than non-modiﬁed tran-
scripts (38).
The TSSs determined by the RNA circularization
procedure were used to predict potential promoters for
the ncRNAs (Figure 2B). The promoters identiﬁed were
all of the s
66 family (39) the major sigma factor in
C. trachomatis) but functional characterization of the
promoters was not performed and these remain predicted
promoter elements at this point. Two of the ncRNA
promoters have sequences characterized as encoding
‘extended’  10 regions (40). Interestingly, one of these is
CTIG675 (IhtA) as our determinations indicated that the
TSS is located six bases downstream of the TSS previously
determined by Grieshaber et al. (15). It is unclear at this
point whether this ﬁnding is due to technical differences in
the methods used or that IhtA may have more than one
promoter, although Albrecht et al. (21) identiﬁed the same
residue as we did for the TSS for IhtA.
Comparison of detection of ncRNAs by intergenic
microarray to deep-sequencing
We have compared our intergenic microarray analysis
with the recently published study by Albrecht et al. (21)
using deep-sequencing. The primary differences between
the studies are the strains used and the times at which
samples were taken. We used C. trachomatis D
Figure 2. Determination of the 50- and 30-ends of chlamydial ncRNAs
using an RNA circularization assay (23). (A) Schematic representation
of the RNA circularization procedure, beginning with the removal of
the 50-pyrophosphate using tobacco acid phosphatase (TAP) followed
by circularization using T4 RNA ligase. Primers were then designed to
amplify the 50/30 junction. (B) The 50- and 30-ends of the ncRNAs
determined in this study. The 50-end is designated the TSS and the
30-end and overall size of the ncRNAs is listed. ncRNAs that contained
non-templated additions at the 30-end (primarily poly-A additions of
different lengths) are indicated by an asterisk. Promoter predictions
were made by examination of the areas immediately upstream of the
TSS. All of the predicted promoters were of the s
66 (major sigma
factor) type and two had an extended  10 sequence.
Figure 3. The chlamydial developmental cycle and persistence induc-
tion and reactivation using IFN-g and carbenicillin. (A) Samples were
collected for northern blotting at the times indicated (IFN, IFN-g per-
sistence; IFN R, IFN-g reactivation; Cb, carbenicllin persistence; Cb R,
carbenicillin reactivation). (B) Titers of samples collected at 48h PI for
each of the experiments (indicated by the asterisks next to time points
in Figure 4A). Both persistence induction conditions resulted in signiﬁ-
cant reductions in IFUs at 48h PI which returned to near normal IFU
numbers following reactivation.
Nucleic Acids Research,2011, Vol.39, No. 5 1849(UW-3/Cx) at 40h PI and they studied C. trachomatis L2b
(UCH-1/proctitis) at 24h PI. The relative strengths and
weaknesses of the two techniques are reviewed in Sharma
and Vogel (19). One particular difﬁculty that pertains to
both procedures however is the ability to remove the vast
excess of host structural RNAs to determine the bacterial
transcriptome. In the Albrecht et al. (21) study, the organ-
isms were gradient puriﬁed to reduce the host background.
This may be somewhat problematic at earlier time points.
However, our analyses were restricted to intergenic
ncRNAs while the deep-sequencing approach allowed
them to detect 25 putative anti-sense ncRNAs that lie
within ORFs. We detected only three anti-sense ncRNAs
that overlap ORFs based on the fact the anti-sense
molecules extended beyond the ORF mRNAs on the
opposite strand. Excluding housekeeping RNAs (i.e.
tRNAs, tmRNA, 4.5S RNA, 5S RNA and M1 RNA)
we found 34 candidate genes, of which 16 were conﬁrmed
by northern blotting. The Albrecht et al. (21) study found
sequence reads for 11 intergenic ncRNAs we predicted.
They conﬁrmed nine of these by northern blotting. Four
intergenic ncRNAs predicted by Albrecht et al. (21) were
not found in our study. Nine ncRNAs were conﬁrmed by
northern blotting by both groups, as shown in Table 1.
They detected two molecules by sequencing that were
predicted by our criteria but which we could not conﬁrm
by northern blotting. The TSS analyses were very similar
for molecules examined in both studies, i.e. IhtA and
CTIG270 had identical TSS and CTIG684, CTIG241 and
CTIG153 differed by 1nt. The reasons for the differences
in ncRNA detection are not clear at this time but may be
related to the sampling time PI or the copy number of the
predicted ncRNA transcripts.
Developmental expression of ncRNAs in C. trachomatis D
To determine the expression patterns of ncRNAs, we
chose to examine (i) expression during the normal devel-
opmental cycle, (ii) expression during IFN-g-induced
persistence and reactivation and (iii) expression during
carbenicillin-induced persistence and reactivation. We
are primarily interested in the expression of ncRNAs
during the development of IFN-g-induced persistence
and reactivation. Carbenicillin-induced persistence was
included to determine changes that were speciﬁc
to IFN-g-induced persistence. DNA/RNA samples for
the developmental cycle were taken at 0, 3, 8, 16, 24
and 48h PI as described previously (8) and shown in
Figure 3A. DNA/RNA was collected from IFN-g-
induced persistent samples at 24, 48, 72h PI and 12, 24,
48, 72h post reactivation (IFN and IFN R in Figure 3A).
IFN-g was used to induce persistence (5ng/ml, as
determined by a pilot titration experiment) and was
added to the media 24h prior to infection. Samples were
reactivated at 24h PI by changing media with IFN-g-free
media containing excess tryptophan (10) and samples were
taken at the times shown in Figure 3A (IFN and IFN R).
Carbenicillin-induced persistence was induced by the
addition of antibiotic (2mg/ml, as determined by a pilot
titration experiment) at the time of infection. DNA/RNA
was collected from carbenicillin-treated samples at 24 and
48h PI and 24, 48 and 72h post reactivation (Cb and Cb
R in Figure 3A). As shown in Figure 3B, IFN-g treatment
resulted in a reduction of IFUs of approximately four logs
at 48h PI. Following reactivation for 48h, the IFU values
returned to  98% of control cultures, indicating that RBs
were present but were in a non-dividing or persistent state.
Similarly, carbenicillin treatment resulted in a distinct
decrease in IFUs at 48h PI, but following removal of
the antibiotic (Cb reactivation), IFU numbers returned
to control levels (Figure 3B).
Genome copy numbers for each of the samples was
determined by qPCR as previously described (22) and
the samples were then thoroughly DNased and RNA
was then re-puriﬁed. Expression of ncRNAs was
determined by northern blotting of RNA samples from
equivalent numbers of bacteria (as determined by
genomic normalization) for the developmental cycle and
carbenicillin persistence. Samples used for IFN-g persist-
ence contained 20% of the genome numbers used for the
other analyses due to the reduced chlamydial biomass
associated with growth in the presence of IFN-g.
Samples have been grouped under each condition to
allow for direct comparisons between normal and persist-
ent growth conditions. The results in Figure 4 show the
ncRNA expression patterns for potential ncRNAs that
showed changes in expression during growth in the
presence of IFN-g (the genomic-locus of each ncRNA is
also shown). The expression of multiple species of
ncRNAs has been previously described for other
bacteria (e.g. in E. coli for gadY, (41) and dsrA (42) and
is believed to involve post-transcriptional processing that
is dependent on the balance between protection by Hfq
and degradation by RNase E. The functional signiﬁcance
has not been well-studied but, importantly Davis and
Waldor (43) have shown that MicX of Vibro cholerae
can be detected as both an active precursor and a
processed form and that the smaller, processed molecule
is signiﬁcantly more stable and abundant. Interestingly,
processing occurs in a Hfq and RNase E-dependent
manner but the regulatory effects of MicX on its target
mRNA are not dependent on Hfq. Chlamydia spp. do not
contain obvious orthologs of Hfq or RNase E suggesting
that regulation and processing may be very different in
these organisms.
Expression of ncRNAs during the normal developmental
cycle and during IFN-c-induced and carbenicillin-induced
persistence
ncRNAs that showed signiﬁcant changes in expression
during IFN-g-induced persistence are shown in Figure 4.
In each case the results of northern blotting are shown for
the complete developmental cycle and compared with
expression patterns during the induction of persistence
and reactivation. CTIG153 was expressed during the
normal developmental cycle from  8 to 24h PI and
expression dropped dramatically by 48h PI. This
molecule was expressed as two species of  159nt and
115nt (Figure 4A). Only the longer species was
amenable to RNA circularization analysis as mentioned
previously. During IFN-g treatment the larger species was
1850 Nucleic Acids Research, 2011,Vol.39, No. 5Figure 4. Developmental expression of ncRNAs in C. trachomatis during the developmental cycle, IFN-g-induced and carbenicillin-induced persist-
ence and reactivation. Each panel (A–H) shows the expression pattern of the particular putative ncRNA under the conditions described in Figure 3.
In addition the genomic position and orientation of the ncRNAs are shown in the schematic panel under the Developmental cycle panel (black
triangles are putative ncRNAs and grey triangles are tRNAs).
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undetectable. Reactivation resulted in expression of both
molecules in similar quantities and expression of both
decreased signiﬁcantly throughout the reactivation
period. Similar ﬁnding were found during carbenicillin-
induced persistence and reactivation, suggesting that
similar processing events occurred during both procedures
(Figure 4A). CTIG241 was expressed later in the develop-
mental cycle ( 16–48h PI) and was barely detectable
during IFN-g-induced persistence. Higher expression
levels were found during the reactivation phase. This
was distinct from the proﬁle found during carbenicillin-
induced persistence where strong expression was found
under the inﬂuence of the antibiotic that waned during
reactivation. The expression of CTIG270 was only
detected late in the developmental cycle (24—48h PI)
and the 222nt species was not detected during IFN-g-
induced persistence or reactivation. During carbenicillin-
induced persistence the same species was only detected at
24h post-reactivation.
The 241nt CTIG360 molecule was detected from  8t o
48h PI with a peak at 16h PI (Figure 4D). This molecule
overlaps the 50-UTR of the bioY gene, a predicted
ortholog of biotin transporters found in other bacterial
species. Interestingly, the 241nt molecule was not
detected during IFN-g-induced resistance but a higher
molecular weight species (>500nt) was clearly detectable.
Following reactivation, the higher molecular weight
species disappeared and the 241nt species reappeared.
This expression pattern was not found during
carbenicillin-induced persistence. This pattern of expres-
sion is similar to that found with other genes or operons
regulated by riboswitches but further studies are needed to
conﬁrm this. Expression of the very small CTIG504 was
determined to be maximal at 16h PI and expression
decreased later in the developmental cycle. Expression
was detected at all points during IFN-g-induced persist-
ence and reactivation while expression was seen during
carbenicillin treatment but was reduced following reacti-
vation. CTIG643 expression was detected at 16 and 24h PI
but was not detected during IFN-g treatment. During
carbenicillin treatment the lower molecular weight
fragment, expressed at low levels during normal develop-
ment, was expressed strongly during treatment but at
declining levels during reactivation.
Expression of CTIG675 was strongest at 16 and 24h PI
and decreased at 48h PI. This molecule was only weakly
expressed during IFN-g-induced persistence but was
expressed at high levels during carbenicillin treatment.
The plasmid anti-sense transcripts were ﬁrst detected at
8h PI and were expressed at high levels during the
mid-cyle. Expression was barely detectable during IFN-g
treatment but the molecules were expressed at high levels
during reactivation. Interestingly, only the lower molecu-
lar weight species was detected during carbenicillin treat-
ment and reactivation. These results, although
preliminary, argue that expression of this group of
putative ncRNAs are developmentally regulated since
identical RNA samples were loaded in each corresponding
lane [e.g. compare the timing of expression of CTIG153
(Figure 4A) and CTIG241 (Figure 4B)].
Figure 5. Analysis of the co-expression of the chlamydial ncRNA
CTIG270 and the chlamydial ftsI gene in E. coli.( A) A schematic
showing the location of CTIG270 and ﬂanking genes. (B) Results of
co-expression assays. Samples were prepared using different
co-induction protocols and samples were tested for the presence of
the FtsI protein and mRNA and CTIG270. The western blot was de-
veloped with an a-Flag-tag antibody. The same samples were run on
SDS-Page gels as loading controls and stained with Coomassie Blue.
Northern blots for ftsI and CTIG270 were done from RNA prepar-
ations from the same samples. The co-induction analysis is shown at
the top of the ﬁgure. The ﬁrst three lanes show the results when stimu-
lation with arabinose for 5h is followed by the addition of IPTG for
different times (boxed region) as indicated. In the second set of three
lanes, IPTG induction for 5h was followed by induction with arabinose
(boxed region) for the times indicated. In the third set of three lanes
induction of both the ncRNA and ftsI were stimulated with IPTG and
arabinose (boxed region) for the times indicated. The results indicated
that expression of CTIG270 results in the degradation of ftsI mRNA.
(C) Co-expression controls in which the lanes shown are analogous to
lane 9 in Figure 5A in that both plasmids are co-induced for the same
length of time. A truncated form of CTIG270 (CTIG270
), which does
not overlap the 30-UTR of ftsI, is expressed in lane 1 but has no inﬂu-
ence on the expression of FtsI. Expression of full-length CTIG270
however results in the degradation both ftsI mRNA and CTIG270
(Figure 5C, lane 2 and as shown in Figure 5A). Expression of an un-
related ncRNA (IhtA) that acts on hctA mRNA (15) also has very little
effect on the expression of FtsI (lane 3). Expression of FtsI was not
affected by the presence of the empty vector pRANGER BTB (lane 4).
(D) Quantitative RT-PCR analysis of the expression proﬁles of ftsI and
CTIG270 throughout the developmental cycle. Measurements were
made in triplicate for each time point.
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heterologous system
FtsI has been shown to play an important role in peptido-
glycan synthesis associated with bacterial cell division in
other systems (44). The general block in cell division
during IFN-g-induced persistence (and most other forms
of chlamydial persistence) led us to examine the effect of
co-expression of these genes in an E. coli system. The
anti-sense nature of CTIG270 and the ftsI gene are
shown in Figure 5A. The ftsI gene was cloned into the
pSMART LCAmp construct containing an in-frame
FLAG-tag insert under the control of the lacZ
promoter/operator system which expressed a FLAG-tag
positive product of the predicted size, i.e. 75kDa
(Figure 5B). The ftsI construct was then co-transformed
into the strain containing the inducible CTIG270 construct
in a pRANGER-cat. Expression studies were done in the
co-transformed strain to determine the effect of CTIG270
expression on FtsI translation (Figure 5). The analysis
indicated that when CTIG270 was induced prior to induc-
tion of the ftsI target gene, no expression of the FtsI
protein or mRNA was seen and that the CTIG270
transcript decreased over the induction period, a result
that is consistent with digestion of both RNAs following
interaction. Induction of the ftsI gene prior to
co-induction of CTIG270 showed that FtsI protein and
ftsI mRNA were made, followed by a transient increase
at 2.5h of arabinose induction [probably due to transient
cross-induction of the lacZ promoter, as reported previ-
ously (45)] and complete disappearance of the protein and
mRNA in the presence of the ncRNA for 5h.
Co-induction of both genes resulted in some expression
of FtsI, ftsI mRNA and CTIG270 at 2.5h, but at 5h the
ftsI mRNA (and therefore the FtsI protein) were not
found. These results are consistent with a base-pairing
interaction of the ncRNA with the target gene resulting
in RNA degradation.
Control experiments are shown in Figure 5C, in which
samples are co-induced as shown for lane 9 in Figure 5B.
Expression of a truncated form of CTIG270, named
CTIG270 is shown in lane 1. This ncRNA lacks the
region of CTIG270 that overlaps the 30-UTR of ftsI.
Expression of this product does not result in the degrad-
ation of ftsI mRNA and expression of FtsI is apparent.
Expression of full length CTIG270 (lane 2, Figure 5C)
results in degradation of both ftsI mRNA and the
CTIG270 ncRNA, as shown previously in Figure 5B.
Expression of an unrelated ncRNA (ihtA) is shown in
lane 3 and there is a very minimal effect on ftsI mRNA
and FtsI protein expression. We believe the slightly lower
amounts of FtsI protein may be due to the general
cytotoxic effect of ihtA expression (15). Expression of
FtsI protein is unaffected in the presence of the empty
vector used to express ncRNAs (Figure 5C, lane 4).
The expression of ftsI and CTIG270 were measured
during the chlamydial developmental cycle using
qRT–PCR with Taqman primer probe sets. In each case
the triplicate measurements were normalized to chlamyd-
ial genome copy numbers as described in the ‘Materials
and Methods’ section. The results indicate that ftsI
mRNA can ﬁrst be detected  10–12h PI and peaks at
 24h PI. After this point the levels of ftsI mRNA
decrease to nearly undetectable levels by 40h PI. The
expression of CTIG270 follows ftsI expression by several
hours and increases throughout the cycle. These data are
consistent with the predicted degradation of ftsI mRNA
by CTIG270 after  24h PI. This does not imply that cell
division stops at this point, as FtsI protein synthesized
during the 10–24–h PI portion of the cycle should not be
affected by CTIG270 expression. Instead, the regulatory
process appears to allow for maximum FtsI expression
during the period of rapid cell division by RBs.
CONCLUSIONS
Chlamydia trachomatis D/UW-3/Cx expresses numerous
ncRNA that can be initially detected using an intergenic
microarray and validated by northern blotting analyses.
These include the subset of potential ncRNAs in this study
which are potential cis-acting (anti-sense) and trans-acting
ncRNAs in addition to a non-coding 50-UTR of the bioY
gene that structurally resembles a riboswitch. We have
shown that these ncRNAs have distinct temporal expres-
sion patterns during the normal developmental cycle and
several appear to have processing steps that result in the
expression of molecules of different molecular weights. We
have also shown that the expression of many ncRNAs is
altered during growth conditions that induce persistent
growth, particularly IFN-g-induced persistence and
carbenicillin-induced-persistence. These studies of
ncRNAs in C. trachomatis provide a strong basis for
mechanistic studies that may determine a role for
ncRNA regulation in the development and persistence of
C. trachomatis.
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